Demeng Chen
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Urology top 2%
- Hair Growth and Disorders
Papers in
-
- RNA modifications and cancer 17
- Cancer-related gene regulation 11
- Epigenetics and DNA Methylation 8
- Ubiquitin and proteasome pathways 5
- Oncology 21
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Radhika P. Atit (3 shared papers)Cun‐Yu Wang (4 shared papers)Andrew Jarrell (2 shared papers)Canting Guo (1 shared paper)Richard A. Lang (1 shared paper)Maosheng Cheng (12 shared papers)Dan Xie (1 shared paper)Bo Li (1 shared paper)
- Journals
- International Journal of Oral Science (5 papers)Journal of Clinical Investigation (3 papers)Oral Diseases (3 papers)Molecular Therapy (3 papers)Cancer Communications (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Demeng Chen
69 papers receiving 3.3k citations
Demeng Chen's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 946
- Urology 210
- Molecular Biology 2.2k
- Oncology 530
- Rehabilitation 102
Countries citing papers authored by Demeng Chen
This map shows the geographic impact of Demeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demeng Chen more than expected).
Fields of papers citing papers by Demeng Chen
This network shows the impact of papers produced by Demeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demeng Chen. The network helps show where Demeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Demeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma Hit paper breakdown → | 2019 | 614 |
| 2 | 2017 | 225 | |
| 3 | 2012 | 208 | |
| 4 | 2017 | 157 | |
| 5 | 2019 | 153 | |
| 6 | 2022 | 144 | |
| 7 | 2020 | 122 | |
| 8 | 2014 | 110 | |
| 9 | 2018 | 108 | |
| 10 | 2021 | 100 | |
| 11 | 2016 | 80 | |
| 12 | 2021 | 77 | |
| 13 | 2018 | 76 | |
| 14 | 2019 | 75 | |
| 15 | 2021 | 73 | |
| 16 | 2019 | 72 | |
| 17 | 2021 | 66 | |
| 18 | 2009 | 64 | |
| 19 | 2021 | 54 | |
| 20 | 2021 | 42 |
About Demeng Chen
Demeng Chen is a scholar working on Molecular Biology, Oncology, Immunology, Surgery and Cancer Research, having authored 70 papers that have together received 3.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (17 papers), Cancer-related gene regulation (11 papers), Cancer Cells and Metastasis (9 papers), Epigenetics and DNA Methylation (8 papers), HVDC Systems and Fault Protection (6 papers), Ubiquitin and proteasome pathways (5 papers), Immune cells in cancer (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (946 citations), Urology (210 citations), Molecular Biology (2.2k citations), Oncology (530 citations) and Rehabilitation (102 citations). Demeng Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Radhika P. Atit, Cun‐Yu Wang, Andrew Jarrell, Canting Guo, Richard A. Lang, Maosheng Cheng, Dan Xie, Bo Li, Dongxin Lin and Zhan‐Hong Chen. Their work appears in journals such as International Journal of Oral Science, Journal of Clinical Investigation, Oral Diseases, Molecular Therapy and Cancer Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.